Target intelligence / Profile preview

Purinergic receptor P2X 2 (P2X2)

Target
P2X2
Molecular classification
Ion channel, Receptor, Ligand-gated ion channel
01

Overview

Purinergic receptor P2X 2 (P2X2) is a member of the P2X family of ligand-gated ion channels that are activated by extracellular ATP[1][2][3]. The functional channel is a trimer composed of three subunits (either homo- or heterotrimeric) and is permeable to sodium, potassium, and calcium ions. P2X2 receptors are widely expressed in neurons, especially in sensory pathways such as auditory circuits and nociceptive (pain) processing systems. Activation of the receptor by ATP leads to rapid depolarization and intracellular signaling events, mediating processes like neurotransmitter release and sensory perception. P2X2 is increasingly studied as a therapeutic target for conditions like neuropathic pain, inflammation, and auditory dysfunction, and several selective agonists and antagonists are in preclinical or early clinical development[1][3]. The structural basis for ATP gating and receptor function has been elucidated using homology models based on related P2X structures, highlighting domains critical for ligand binding and channel gating[1][2].

Other names
P2X2 receptorP2RX2ATP-gated ion channel P2X2
02

Mechanism of action

Agonists (such as ATP) activate the channel, resulting in rapid cation influx (Na⁺, Ca²⁺, K⁺)[1][2][3]. Antagonists inhibit ATP binding or channel opening, thus blocking cation conductance and downstream signaling[1][2][3].

03

Biological functions

Signal transductionSynaptic transmissionSensory neurotransmissionModulation of neuronal excitability
04

Disease associations

Neuropathic painHearing loss (auditory processing)InflammationSensory disorders
05

Safety considerations

Targeting P2X2 may affect essential physiological signaling in the nervous system.Potential for off-target sensory or neuronal dysfunction (e.g., impacts on hearing or pain perception) due to channel’s role in synaptic transmission[1].Limited clinical data on safety—concerns inferred from preclinical targets.
06

Interacting drugs

ATP (agonist)

6 more in the full profile.

07

Biomarkers

Expression of P2X2 in specific neuronal regions (auditory pathways, sensory neurons) may serve as a biomarker for certain sensory processing or neuropathic states, but there are no universally validated circulating biomarkers for monitoring P2X2 activity.

Beyond the preview

Go deeper on Purinergic receptor P2X 2 (P2X2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Purinergic receptor P2X 2 (P2X2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call